Gastrointestinal Cancer
News
No Panitumumab Benefit Seen in Colorectal Cancer with KRAS Mutations
Major Finding: There were no consistent associations across trials between the most common codon 12 and 13 KRAS mutant alleles and progression-...
News
Regorafenib Anticipated to Show Survival Advantage in Colorectal Cancer
News
Old Antivirals Rival New for Cancer Prevention in Hepatitis B
Major Finding: The rate of hepatocellular carcinoma was 0.013-0.017 per person-year of follow-up with lamivudine, 0.015 with adefovir with or...
News
Smoking Doubles Cancer Risk in Barrett's Esophagus
Major Finding: After adjustment for demographics, presence of low-grade dysplasia, reflux symptoms, and Barrett’s segment length at diagnosis,...
News
Therapies Can Extend Life in Infiltrative Liver Cancer
Major Finding: Transcatheter arterial chemoembolization/ radiofrequency ablation gives patients with infiltrative HCC an extra 3 months of life on...
Case Reports
Posterior reversible encephalopathy syndrome: a potential side effect of gemcitabine
News
Medicare Study Confirms Colonoscopy's Cancer Prevention Power
Major Finding: Colonoscopy was associated with a 73% lower risk of distal colorectal cancer (hazard ratio, 0.27) and a 54% lower risk of proximal...
News
Long-Term Risk of GI Cancers Not Elevated in Celiac Patients
Major Finding: Overall, celiac disease patients do not have a significantly elevated risk of gastrointestinal cancers, nor do patients with celiac...
News
Novel Hep C Treatment Excludes Peginterferon Alfa
Major Finding: A novel regimen that did not include peginterferon alfa resulted in a 100% virologic response rate in patients with hepatitis C...
News
Study Supports HBV Screening, Prophylaxis in Chemotherapy Patients
Major Finding: Among patients whose hepatitis B reactivated during chemotherapy, mortality was much lower for those who had received prophylaxis...
News
Possible Cancer Link to Diabetes Drugs Stirs Controversy
Major Finding: The risk of pancreatic cancer was increased with exenatide and sitagliptin versus control treatments, with respective odds ratios...